Archive for 'Tag Archives: 'Disease''
Over the past 8 years, ZenTech Biotechnology, a company headquartered in Liège Science Park and specializing in the diagnostic of pathologies occurring in prenatal, neonatal and pediatrics stages, deployed a strong internationalization strategy and is now [...]
An article in the Japanese press is praising the quality of research in cellular therapy at the UCL within the laboratory of Prof. Etienne Sokal and at Louvain-born spin-off Promethera Biosciences. The article on regenerative medicine, [...]
Artialis’ biomarker technology provides early detection of joint disorders and effective monitoring of treatments, confirming Tilman’s plant based supplement offers effective treatment
Artialis(Liège) and Tilman(Baillonville), two Wallonia-based biotech companies specialized in joint disorders and medicinal plant therapy respectively, through combined efforts are making a name for themeselves with effective “natural” treatment of joint disorders. Everyone knows joints can [...]
Galephar will soon launch phase 1 clinical trials to confirm the effectiveness of new inhaled synergetic combinations in the treatment of cystic fibrosis. Here lies yet another example of how Biowin, through its R & [...]
Euroscreen has recently announced the completion of a €10 million Series A preferred stock financing led by Vesalius Biocapital II Partners and SRIW(Société Régionale d’Investissement de Wallonie SA). The proceeds of the round will mainly be used to fund and develop the [...]
Promethera Biosciences of Belgium attracts international investors allowing promising future for treatment of liver disease.
UCL spin off biotechnology company Promethera Biosciences (Mont-Saint Guibert, Wallonia/Belgium), with the help and support of pharmaceutical groups and investors worldwide, is targeting a medical breakthrough with an innovative therapeutic cell product designed to treat liver [...]
UCB and Harvard University will officially launch their innovative Research Alliance. The Alliance creates a unique drug discovery bridge between industry and academia, with Harvard scientists continuing their research that holds potential for the development of [...]